ESOC 2026 | Addressing sex-based disparities in stroke prevention and care
Cheryl Carcel, MD, PhD, University of New South Wales, Kensington, Australia, discusses practical strategies to reduce sex-based disparities in stroke prevention and care. Dr Carcel highlights the importance of recognizing female-specific risk factors, ensuring equitable access to treatment, increasing the enrollment of women in clinical trials, and supporting long-term adherence to preventive therapies. This interview took place at the 12th European Stroke Organisation Conference (ESOC) in Maastricht, The Netherlands.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Transcript
This is exactly what we addressed in our World Stroke Organization scientific statement on sex and gender differences in stroke risk and management. So the advice there is the proposed solutions and future direction is number one looking at gender-responsive treatment and something I mentioned a bit earlier is in our clinics, are we asking women about these important female-specific risk factors? Are we ensuring that people who come into the hospital, are we ensuring that they have equitable access to care? The other things we can do is, again, note those female-specific risk factors, enroll more women in clinical trials, ensure that everyone has access to care and are sustained in that medication use, not just men or women, but everybody...
This is exactly what we addressed in our World Stroke Organization scientific statement on sex and gender differences in stroke risk and management. So the advice there is the proposed solutions and future direction is number one looking at gender-responsive treatment and something I mentioned a bit earlier is in our clinics, are we asking women about these important female-specific risk factors? Are we ensuring that people who come into the hospital, are we ensuring that they have equitable access to care? The other things we can do is, again, note those female-specific risk factors, enroll more women in clinical trials, ensure that everyone has access to care and are sustained in that medication use, not just men or women, but everybody.
This transcript is AI-generated. While we strive for accuracy, please verify this copy with the video.
Read more...
